Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q3 2019

Top Holdings414 positions

Checking export access…
Activity:

Meta Platforms Inc

72.7M$12.9B4.2%$131.74+33.89%
4 qtrssince 2018-Q4
Decreased
0

Microsoft Corp.

92.9M$12.9B4.2%$94.43+38.43%
4 qtrssince 2018-Q4
Decreased
0

Abbott Laboratories

113.1M$9.5B3.1%$62.94+16.92%
4 qtrssince 2018-Q4
Decreased
0

Netflix, Inc.

35.3M$9.4B3.1%$27.49-2.65%
4 qtrssince 2018-Q4
Increased
72

AbbVie Inc.

100.6M$7.6B2.5%$66.47-14.47%
4 qtrssince 2018-Q4
Decreased
0

Broadcom Inc

27.2M$7.5B2.5%$21.51+8.70%
4 qtrssince 2018-Q4
Increased
55

Amazon.com, Inc.

4M$7B2.3%$75.10+15.58%
4 qtrssince 2018-Q4
Decreased
0

Amgen Inc.

33.6M$6.5B2.1%$154.24+1.54%
4 qtrssince 2018-Q4
Increased
62

UnitedHealth Group Inc.

22.6M$4.9B1.6%$216.78-11.20%
4 qtrssince 2018-Q4
Increased
51

GILEAD SCIENCES INC

76.8M$4.9B1.6%$47.29+3.44%
4 qtrssince 2018-Q4
Decreased
0

MasterCard Incorporated

17.7M$4.8B1.6%$182.23+43.21%
4 qtrssince 2018-Q4
Increased
51

General Dynamics Corporation

26.2M$4.8B1.6%$134.76+15.59%
4 qtrssince 2018-Q4
Increased
54
BABABABA
ADR

ALIBABA GROUP HLDG LTD

27.2M$4.6B1.5%$143.24+9.87%
4 qtrssince 2018-Q4
Decreased
0

EXXON MOBIL CORP

61.7M$4.4B1.4%$50.02+6.15%
4 qtrssince 2018-Q4
Increased
51

Alphabet Inc.

3.4M$4.2B1.4%$51.76+16.86%
4 qtrssince 2018-Q4
Decreased
0

Home Depot Inc.

16.4M$3.8B1.2%$143.63+35.88%
4 qtrssince 2018-Q4
Decreased
0

EOG Resources Inc.

50.2M$3.7B1.2%$63.87-13.93%
4 qtrssince 2018-Q4
Increased
53

Alphabet Inc.

3M$3.7B1.2%$51.29+17.71%
4 qtrssince 2018-Q4
Decreased
0

CSX CORP

52.5M$3.6B1.2%$19.28+9.15%
4 qtrssince 2018-Q4
Increased
58

Thermo Fisher Scientific Inc

12M$3.5B1.1%$219.16+30.42%
4 qtrssince 2018-Q4
Decreased
0
$304.9B
AUM
414
Positions
Q3 2019
Filing
HI score · 4.0/5
Quarterly 13F Value Change
+10%Q1'19$315.5B-0%Q2'19$315B-3%Q3'19$304.9B
Activity profile
$ moved · Q3'19
New14%Increased33%Decreased42%Exited10%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.5 quarters
<1Q9%1-4Q91%1-2Y0%2Y+0%

Capital Research Global Investors manages $304.9B across 414 positions as of Q3 2019. Top holdings: META (4.2%), MSFT (4.2%), ABT (3.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q3 2019 Summary

Active quarter - 40 new positions, 27 exits, 167 increased. Top move: NFLX (INCREASED, conviction 72). Portfolio: $304.9B across 414 positions.

Top holdings by portfolio weight

Total AUM$305B
META4.25%
MSFT4.24%
ABT3.10%
NFLX3.10%
ABBV2.50%
AVGO2.46%
AMZN2.30%
AMGN2.13%
UNH1.61%
GILD1.60%
Other1.58%

Portfolio allocation by GICS sector

Sectors11
Healthcare18.96%
Technology16.65%
Consumer Cyclical11.74%
Communication Services11.63%
Industrials8.05%
Financial Services7.81%
Consumer Defensive6.38%
Energy6.06%
Unknown4.77%
Basic Materials3.33%
Other4.63%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOALTRIA GROUP INC
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAMERICAN ELEC PWR CO INC
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corporation
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used